Insider Stock Trading History of Randall Lorin


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Randall Lorin since year 2005. The trader's CIK number is 1352452. At the time of this reporting, Randall Lorin is the Director of Acorda Therapeutics Inc . (stock ticker symbol ACOR). See this page for all insider trading activities at Acorda Therapeutics Inc .

Note that in the past Randall Lorin also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Randall Lorin since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-07-31 ACOR Acorda Therapeutics Inc Option Ex 10,000 18.21 182,100
2017-07-31 ACOR Acorda Therapeutics Inc Sale 10,000 21.66 216,620
2016-04-19 ACOR Acorda Therapeutics Inc Option Ex 1,488 18.65 27,751
2016-04-19 ACOR Acorda Therapeutics Inc Sale 1,488 28.68 42,675
2013-09-04 TNGN Tengion Inc Sale 379 .63 238
2012-11-28 ACOR Acorda Therapeutics Inc Sale 10,198 24.70 251,900
2012-11-28 ACOR Acorda Therapeutics Inc Option Ex 10,198 6.00 61,188
2011-05-20 ACOR Acorda Therapeutics Inc Option Ex 2,500 6.00 15,000
2011-05-20 ACOR Acorda Therapeutics Inc Sale 2,500 31.60 79,000
2011-01-10 ACOR Acorda Therapeutics Inc Option Ex 5,000 6.00 30,000
2011-01-10 ACOR Acorda Therapeutics Inc Sale 5,000 30.00 150,000
2010-08-11 ACOR Acorda Therapeutics Inc Option Ex 5,000 6.00 30,000
2010-08-11 ACOR Acorda Therapeutics Inc Sale 5,000 33.52 167,600
2009-08-12 ACOR Acorda Therapeutics Inc Option Ex 10,000 6.00 60,000
2009-08-12 ACOR Acorda Therapeutics Inc Sale 10,000 23.58 235,799

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Randall Lorin (Director of Acorda Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.